FDA inspection
AstraZeneca Pharmaceuticals LP: FDA inspection ending Jan 24, 2012
FDA inspection 783452 · Administrative/Directed Change (ADC) · Mount Vernon, IN
Key facts
| Inspection ID | 783452 |
|---|---|
| Firm | AstraZeneca Pharmaceuticals LP |
| FEI number | 1825662 |
| Address | 4601 Highway 62 E |
| City | Mount Vernon |
| State | IN |
| ZIP | 47620-9682 |
| Fiscal year | 2012 |
| Inspection end date | Jan 24, 2012 |
| Classification | Administrative/Directed Change (ADC) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data